Liraglutide
Also known as: victoza, saxenda, NN2211
Long-acting GLP-1 analogue studied for metabolic syndrome, obesity, and cardiovascular risk models.
Quick Reference
Liraglutide - Research Images
PSO vial render · Scientific images from Wikipedia · Tap to enlarge
Overview
Anti-diabetic medication
Liraglutide, sold under the brand names Victoza and Saxenda among others, is an anti-diabetic medication used to treat type 2 diabetes, and chronic obesity. It is a second-line therapy for diabetes following first-line therapy with metformin. Its effects on long-term health outcomes like heart disease and life expectancy are unclear. It is given by injection under the skin.
Mechanism of Action
Liraglutide, sold under the brand names Victoza and Saxenda among others, is an anti-diabetic medication used to treat type 2 diabetes, and chronic obesity. It is a second-line therapy for diabetes following first-line therapy with metformin. Its effects on long-term health outcomes like heart disease and life expectancy are unclear. It is given by injection under the skin.
What Researchers Are Saying
Community Reports - Not Medical Advice
The following is aggregated from public forums, Reddit, and research communities. These are anecdotal reports from researchers only - not verified clinical data and not a recommendation of any kind.
Liraglutide (also known as victoza, saxenda) is studied within the metabolic health research community. Long-acting GLP-1 analogue studied for metabolic syndrome, obesity, and cardiovascular risk models.
Last updated October 28, 2026
Research status: active. Liraglutide appears across metabolic health research forums and academic literature. Researchers note this compound falls in the metabolic category.
Last updated October 28, 2026
What Do You Think of This Peptide?
Share your opinion or research experience with Liraglutide. Comments are reviewed before appearing.